Kenneth Zucker: The Psychologist Gender Activists Tried to Silence (#31)
21 August 2025
With Kenneth Zucker
North America
Dr Kenneth Zucker directed North America's first paediatric gender clinic for four decades and helped write three editions of the DSM. In 2015 he was forced out by activists who called his careful, assessment-based practice conversion therapy — and he won an $800,000 settlement with a public apology. This episode draws on his unparalleled clinical and research record to examine what the data actually show about childhood gender dysphoria, why early social transition appears to change long-term outcomes, and how ideology displaced evidence in a field that once prioritised watchful, careful care.
Dr Kenneth Zucker is one of the most significant and most contested figures in the history of gender medicine. For four decades he directed the Gender Identity Service at Toronto's Centre for Addiction and Mental Health, a clinic that had grown from its establishment around 1975 into arguably the first formal paediatric gender service in North America. He also chaired the DSM-5 work group on Sexual and Gender Identity Disorders and contributed to revisions of DSM-3R and DSM-4, giving him an unusually direct role in shaping how the medical and psychiatric professions have defined and categorised gender dysphoria over nearly fifty years. In this episode, Zucker traces the diagnostic journey from "gender identity disorder" in earlier DSM editions to "gender dysphoria" in DSM-5, explaining the reasoning behind those shifts. He also addresses what he sees as a fundamental contradiction at the heart of contemporary gender medicine: the claim, associated with bodies such as WPATH, that gender non-conformity is simultaneously a natural variation requiring no intervention and a medical condition requiring hormonal and surgical treatment. For anyone monitoring how these frameworks shape clinical practice in Ireland, that tension is directly relevant. The HSE has been reassessing its approach to paediatric gender services in the wake of intensifying international scrutiny, including independent reviews that raised serious questions about the evidence base for affirmation-only pathways. The most striking empirical claim in the episode concerns desistance — the phenomenon whereby children who present with gender dysphoria in childhood do not go on to identify as transgender in adulthood. Zucker's own Toronto clinic data showed an approximately 80 per cent desistance rate. He contrasts this sharply with newer research by Christina Olson, whose cohort of socially transitioned children shows an 88 per cent persistence rate. Zucker's interpretation is that early social transition itself changes outcomes: once a child is living as the opposite sex, the likelihood of later desistance falls dramatically, to around 12 per cent. This is not a minor statistical difference. It constitutes a serious argument that what is often framed as a neutral, reversible social step may in practice set a clinical trajectory that is far harder to reverse. The episode also covers the circumstances that ended Zucker's tenure at CAMH. In 2015 his clinic was closed following a campaign by gender-identity activists who accused him and colleagues of practising conversion therapy — a serious charge that Zucker has consistently denied. He subsequently sued the institution and received a settlement of approximately $800,000 together with a formal public apology. The episode examines how activists managed to equate cautious, assessment-based clinical work with the kind of coercive anti-gay practices that gave conversion therapy its rightly damaged reputation — and what that conflation has cost the field. For Irish audiences, the stakes of this conversation are concrete. Ireland enacted some of the world's most progressive gender-recognition legislation in 2015, and questions about how legal self-identification interacts with clinical care for children remain live and unresolved. With paediatric gender services in Ireland limited in number and currently under review, understanding both the clinical evidence and the organised effort to suppress inconvenient research findings is essential background for anyone trying to engage honestly with this policy debate.
